Citation Impact
Citing Papers
The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.
1994 Standout
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
2006 Standout
Transforming growth factor–β3 is required for secondary palate fusion
1995 Standout
A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1
1999 Standout
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
1999 StandoutNobel
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Phenotypic conversion of T lymphoblastic lymphoma to acute biphenotypic leukemia composed of lymphoblasts and myeloblasts. Molecular genetic evidence of the same clonal origin.
1988 StandoutNobel
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
1998 Standout
Tight junction-related structures in the absence of a lumen: Occludin, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas
2003
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
1992 StandoutNature
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
2001 StandoutNobel
Transforming growth factor-β induces development of the TH17 lineage
2006 StandoutNature
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
An essential role for Scurfin in CD4+CD25+ T regulatory cells
2003 StandoutNobel
A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.
1991 StandoutNobel
Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
1999 StandoutNobel
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.
1990
Graft-versus-host disease
2009 Standout
The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.
1992 StandoutNobel
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
2013 Standout
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
The Fas Death Factor
1995 StandoutScience
Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.
1989
Transforming Growth Factor β in Tissue Fibrosis
1994 Standout
Single amino-acid changes in HIV envelope affect viral tropism and receptor binding
1989 StandoutNatureNobel
Cytokine Signaling in 2002
2002 Standout
Points of control in inflammation
2002 StandoutNature
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
1994 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
STATs: transcriptional control and biological impact
2002 Standout
Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice
2002 StandoutNobel
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
TGF-β SIGNAL TRANSDUCTION
1998 Standout
Constitutive synthesis of tumor necrosis factor in the thymus.
1992 StandoutNobel
Association of lpr gene with graft-vs.-host disease-like syndrome.
1985
Control of Autoimmune Myocarditis and Multiorgan Inflammation by Glucocorticoid-Induced TNF Receptor Family-Related Proteinhigh, Foxp3-Expressing CD25+ and CD25− Regulatory T Cells
2006 StandoutNobel
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Induction of cutaneousgraft-versus-hostdisease by local injection of unprimed T cells
1991
Viral and Bacterial Infections Interfere with Peripheral Tolerance Induction and Activate CD8+ T Cells to Cause Immunopathology
1998
Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
1987
Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease.
1990
Nitric oxide and the immune response
2001 Standout
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
Interactions of the UVRABC endonuclease in vivo and in vitro with DNA damage produced by antineoplastic anthracyclines.
1984
The Amount of Scurfin Protein Determines Peripheral T Cell Number and Responsiveness
2001 StandoutNobel
CD28 disruption exacerbates inflammation in Tgf-β1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-β1
2004 StandoutNobel
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
2003 Standout
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
1984 StandoutNature
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Malignant lymphoma, lymphoblastic
1976
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
1993 Standout
Nitric Oxide Mediation of Active Immunosuppression Associated With Graft-Versus-Host Reaction
1999
Graft‐versus‐Host Disease
1985
Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells.
1987 StandoutNobel
The Anthracycline Antineoplastic Drugs
1981 Standout
Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.
1991
CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production
1998 Standout
Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1)
2002
Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
1976 Standout
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Works of D Dantchev being referenced
Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
1975
Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers.
1979
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma
1978
Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy.
1979
Human thymocyte differentiation: an ultrastructural study using monoclonal antibodies and immunogold staining method.
1986
T and B lymphocyte markers on the neoplastic cell of 20 patients with acute and 10 patients with chronic lymphoid leukemia.
1974